Title |
Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD
|
---|---|
Published in |
International Journal of Chronic Obstructive Pulmonary Disease, August 2017
|
DOI | 10.2147/copd.s141695 |
Pubmed ID | |
Authors |
Stephanie Everaerts, Katrien Lagrou, Adriana Dubbeldam, Natalie Lorent, Kristina Vermeersch, Erna Van Hoeyveld, Xavier Bossuyt, Lieven J Dupont, Bart M Vanaudenaerde, Wim Janssens |
Abstract |
Bronchiectasis-chronic obstructive pulmonary disease (COPD) overlap presents a possible clinical phenotype of COPD, but it is unclear why it develops in a subset of patients. We hypothesized that sensitization to Aspergillus fumigatus (A fum) is associated with bronchiectasis in COPD and occurs more frequently in vitamin D-deficient patients. This observational study investigated sensitization to A fum in an outpatient clinical cohort of 300 COPD patients and 50 (ex-) smoking controls. Total IgE, A fum-specific IgE against the crude extract and against the recombinant antigens and A fum IgG were measured using ImmunoCAP fluoroenzyme immunoassay. Vitamin D was measured by radioimmunoassay, and computed tomography images of the lungs were scored using the modified Reiff score. Sensitization to A fum occurred in 18% of COPD patients compared to 4% of controls (P=0.0110). In all, 31 COPD patients (10%) were sensitized to the crude extract and 24 patients (8%) had only IgE against recombinant antigens. A fum IgG levels were significantly higher in the COPD group (P=0.0473). Within COPD, A fum-sensitized patients were more often male (P=0.0293) and more often had bronchiectasis (P=0.0297). Pseudomonas aeruginosa and Serratia marcescens were more prevalent in historical sputum samples of A fum-sensitized COPD patients compared to A fum-non-sensitized COPD patients (P=0.0436). Vitamin D levels were comparable (P=0.2057). Multivariate analysis demonstrated that sensitization to recombinant f1 or f3 had a 2.8-fold increased risk for bronchiectasis (P=0.0030). These results highlight a potential role for sensitization to A fum in COPD-related bronchiectasis. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 4 | 15% |
Venezuela, Bolivarian Republic of | 3 | 11% |
Argentina | 2 | 7% |
Panama | 1 | 4% |
Germany | 1 | 4% |
United Kingdom | 1 | 4% |
Nicaragua | 1 | 4% |
Turkey | 1 | 4% |
United States | 1 | 4% |
Other | 1 | 4% |
Unknown | 11 | 41% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 19 | 70% |
Scientists | 4 | 15% |
Practitioners (doctors, other healthcare professionals) | 3 | 11% |
Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 63 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 8 | 13% |
Student > Ph. D. Student | 7 | 11% |
Student > Postgraduate | 6 | 10% |
Other | 4 | 6% |
Student > Master | 4 | 6% |
Other | 18 | 29% |
Unknown | 16 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 31 | 49% |
Arts and Humanities | 2 | 3% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Immunology and Microbiology | 2 | 3% |
Environmental Science | 1 | 2% |
Other | 5 | 8% |
Unknown | 20 | 32% |